Table 4.
Toxicity profile of patients treated by SBRT boost
| Fatigue |
9 (56%) |
| Cough |
8 (50%) |
| Shortness of Breath |
3 (18.8%) |
| Chest pain |
4 (25%) |
| Hemoptysis |
1 (6%) |
| Esophagitis |
3 (18.8%) |
| Pneumonitis | 4 (25%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.